• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别差异与心血管风险因素认知:ESC EORP EUROASPIRE V 注册研究结果。

Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.

机构信息

Department of Public Health and Primary Care, Ghent University, Belgium.

National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland; Imperial College Healthcare NHS Trust, London, UK.

出版信息

Int J Cardiol. 2022 Apr 1;352:152-157. doi: 10.1016/j.ijcard.2022.01.059. Epub 2022 Feb 3.

DOI:10.1016/j.ijcard.2022.01.059
PMID:35122913
Abstract

BACKGROUND

Patients' risk factor awareness is essential to decrease the risk of recurrent coronary events. The aim of this study was to provide up-to-date evidence on existing gender differences in the patients' knowledge of risk factors and information provided by healthcare professionals.

METHODS

Analyses were based on the cross-sectional ESC EORP EUROASPIRE V survey, including data on CHD patients across 27 European countries. Consecutive patients (18-80 years), hospitalized for a coronary event or surgical procedure, were retrospectively identified. Information on risk factor awareness was collected from medical records, medical examination, and structured questionnaires during the study visit (six months to two years after hospitalization).

RESULTS

Patient information was available for 8261 patients, of which 25.8% were women. Although women with obesity were significantly less aware about their actual (OR = 0.66, CI = 0.52-0.85) and target weight levels (OR = 0.66, CI = 0.54-0.81), no significant gender differences in risk factor awareness were found in disfavour of women. Remarkably, women with hypertension and women with raised low-density lipoprotein cholesterol (LDL-C) levels were even more aware about their target blood pressure levels (OR = 1.21, CI = 1.01-1.46) and actual cholesterol levels (OR = 1.18, CI = 1.02-1.36), respectively. Moreover, there is some indication that women were more informed by a healthcare professional if they had raised CHD risk factor levels.

CONCLUSIONS

Our study showed only few gender differences in disfavour of women in terms of risk factor awareness and information provided by a healthcare professional. Nevertheless, previous EUROASPIRE V findings demonstrated that women still have a poorer risk factor control in secondary CHD prevention.

摘要

背景

患者对危险因素的认识对于降低复发性冠心病事件的风险至关重要。本研究旨在提供有关现有性别差异的最新证据,包括患者对危险因素的认识以及医疗保健专业人员提供的信息。

方法

分析基于欧洲心脏病学会(ESC)EORP EUROASPIRE V 横断面调查的数据,该调查包括来自 27 个欧洲国家的冠心病患者数据。回顾性识别因冠心病事件或手术住院的连续患者(18-80 岁)。在研究访问期间(住院后 6 个月至 2 年),通过病历、体检和结构化问卷收集有关危险因素意识的信息。

结果

患者信息可用于 8261 名患者,其中 25.8%为女性。尽管肥胖女性对其实际(OR=0.66,CI=0.52-0.85)和目标体重水平的认识明显较低,但在不利的风险因素意识方面,并未发现明显的性别差异。值得注意的是,患有高血压和患有高胆固醇水平的女性对其目标血压水平(OR=1.21,CI=1.01-1.46)和实际胆固醇水平(OR=1.18,CI=1.02-1.36)的认识甚至更高。此外,有迹象表明,如果女性的冠心病危险因素水平升高,她们更有可能得到医疗保健专业人员的告知。

结论

我们的研究仅表明,在风险因素意识和医疗保健专业人员提供的信息方面,女性的性别差异较少。然而,以前的 EUROASPIRE V 研究结果表明,女性在二级冠心病预防中的危险因素控制仍然较差。

相似文献

1
Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.性别差异与心血管风险因素认知:ESC EORP EUROASPIRE V 注册研究结果。
Int J Cardiol. 2022 Apr 1;352:152-157. doi: 10.1016/j.ijcard.2022.01.059. Epub 2022 Feb 3.
2
Gender differences in lifestyle management among coronary patients and the association with education and age: results from the ESC EORP EUROASPIRE V registry.冠心病患者生活方式管理中的性别差异及其与教育和年龄的关系:ESC EORP EUROASPIRE V 注册研究结果。
Eur J Cardiovasc Nurs. 2022 Oct 14;21(7):717-723. doi: 10.1093/eurjcn/zvab129.
3
Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry.冠心病患者危险因素控制的性别差距远未缩小:来自欧洲心脏病学会 EUROASPIRE V 注册研究的结果。
Eur J Prev Cardiol. 2022 Mar 11;29(2):344-351. doi: 10.1093/eurjpc/zwaa144.
4
Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.冠心病患者的危险因素管理和药物治疗中的性别差异:EUROASPIRE IV 和 EUROASPIRE V 调查的比利时结果。
Acta Cardiol. 2023 Jul;78(5):607-613. doi: 10.1080/00015385.2023.2169439. Epub 2023 Feb 13.
5
Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry.冠心病患者的治疗:是否仍存在性别差距?来自欧洲心脏病学会 EUROASPIRE V 注册研究的结果。
Cardiovasc Drugs Ther. 2021 Aug;35(4):801-808. doi: 10.1007/s10557-020-07095-6. Epub 2020 Oct 17.
6
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.27 个国家的冠心病患者生活方式及对心血管危险因素控制的影响:欧洲心脏病学会 ESC-EORP EUROASPIRE V 注册研究结果。
Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.
7
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.在血糖异常和冠心病患者中筛查葡萄糖紊乱、心血管风险因素管理和预后的性别差异:来自 ESC-EORP EUROASPIRE 调查的结果。
Cardiovasc Diabetol. 2021 Feb 11;20(1):38. doi: 10.1186/s12933-021-01233-6.
8
Chronic medication intake in patients with stable coronary heart disease across Europe: Evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry.欧洲稳定型冠心病患者的慢性药物治疗:来自日常临床实践的证据。ESC EORP 欧洲心血管疾病预防和糖尿病调查(EUROASPIRE IV)登记处的结果。
Int J Cardiol. 2020 Feb 1;300:7-13. doi: 10.1016/j.ijcard.2019.09.015. Epub 2019 Sep 7.
9
EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.欧洲冠心病二级预防调查(EUROASPIRE):主要结果。EUROASPIRE研究组。通过干预减少事件的欧洲二级预防行动。
Eur Heart J. 1997 Oct;18(10):1569-82. doi: 10.1093/oxfordjournals.eurheartj.a015136.
10
Gender differences in health-related quality of life and psychological distress among coronary patients: Does comorbidity matter? Results from the ESC EORP EUROASPIRE V registry.冠心病患者健康相关生活质量和心理困扰的性别差异:合并症有影响吗?欧洲心脏病学会(ESC)欧洲动脉粥样硬化患病率和干预效果研究(EUROASPIRE)V注册研究结果
Int J Cardiol. 2023 Jan 15;371:452-459. doi: 10.1016/j.ijcard.2022.09.010. Epub 2022 Sep 8.

引用本文的文献

1
Sex-Based Risk Evaluation in Acute Coronary Events-A Study Conducted on an Eastern-European Population.急性冠脉事件中基于性别的风险评估——一项针对东欧人群的研究
Medicina (Kaunas). 2025 Jul 6;61(7):1227. doi: 10.3390/medicina61071227.
2
Risk factor clustering in men and women with CHD in the Southern Cone of Latin America.拉丁美洲南锥体地区冠心病男性和女性患者的危险因素聚集情况。
Int J Cardiol Cardiovasc Risk Prev. 2023 Jan 13;16:200172. doi: 10.1016/j.ijcrp.2023.200172. eCollection 2023 Mar.
3
Update on Management of Cardiovascular Diseases in Women.
女性心血管疾病管理的最新进展
J Clin Med. 2022 Feb 22;11(5):1176. doi: 10.3390/jcm11051176.